8-86654023-T-G

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_019098.5(CNGB3):​c.892A>C​(p.Thr298Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.653 in 1,596,206 control chromosomes in the GnomAD database, including 342,002 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.65 ( 31980 hom., cov: 32)
Exomes 𝑓: 0.65 ( 310022 hom. )

Consequence

CNGB3
NM_019098.5 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.39
Variant links:
Genes affected
CNGB3 (HGNC:2153): (cyclic nucleotide gated channel subunit beta 3) This gene encodes the beta subunit of a cyclic nucleotide-gated ion channel. The encoded beta subunit appears to play a role in modulation of channel function in cone photoreceptors. This heterotetrameric channel is necessary for sensory transduction, and mutations in this gene have been associated with achromatopsia 3, progressive cone dystrophy, and juvenile macular degeneration, also known as Stargardt Disease. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a topological_domain Cytoplasmic (size 30) in uniprot entity CNGB3_HUMAN there are 8 pathogenic changes around while only 0 benign (100%) in NM_019098.5
BP4
Computational evidence support a benign effect (MetaRNN=1.7230448E-6).
BP6
Variant 8-86654023-T-G is Benign according to our data. Variant chr8-86654023-T-G is described in ClinVar as [Benign]. Clinvar id is 95929.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-86654023-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.767 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNGB3NM_019098.5 linkc.892A>C p.Thr298Pro missense_variant Exon 7 of 18 ENST00000320005.6 NP_061971.3 Q9NQW8-1
CNGB3XM_011517138.3 linkc.478A>C p.Thr160Pro missense_variant Exon 5 of 16 XP_011515440.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNGB3ENST00000320005.6 linkc.892A>C p.Thr298Pro missense_variant Exon 7 of 18 1 NM_019098.5 ENSP00000316605.5 Q9NQW8-1
CNGB3ENST00000681546.1 linkn.712A>C non_coding_transcript_exon_variant Exon 2 of 13
CNGB3ENST00000681746.1 linkn.892A>C non_coding_transcript_exon_variant Exon 7 of 19 ENSP00000505959.1 A0A5J6DSN8

Frequencies

GnomAD3 genomes
AF:
0.648
AC:
98328
AN:
151792
Hom.:
31976
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.633
Gnomad AMI
AF:
0.715
Gnomad AMR
AF:
0.606
Gnomad ASJ
AF:
0.705
Gnomad EAS
AF:
0.788
Gnomad SAS
AF:
0.763
Gnomad FIN
AF:
0.647
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.643
Gnomad OTH
AF:
0.655
GnomAD3 exomes
AF:
0.661
AC:
165844
AN:
251026
Hom.:
55316
AF XY:
0.668
AC XY:
90668
AN XY:
135696
show subpopulations
Gnomad AFR exome
AF:
0.636
Gnomad AMR exome
AF:
0.566
Gnomad ASJ exome
AF:
0.712
Gnomad EAS exome
AF:
0.796
Gnomad SAS exome
AF:
0.765
Gnomad FIN exome
AF:
0.648
Gnomad NFE exome
AF:
0.642
Gnomad OTH exome
AF:
0.646
GnomAD4 exome
AF:
0.653
AC:
943185
AN:
1444296
Hom.:
310022
Cov.:
30
AF XY:
0.658
AC XY:
473276
AN XY:
719742
show subpopulations
Gnomad4 AFR exome
AF:
0.625
Gnomad4 AMR exome
AF:
0.573
Gnomad4 ASJ exome
AF:
0.713
Gnomad4 EAS exome
AF:
0.797
Gnomad4 SAS exome
AF:
0.766
Gnomad4 FIN exome
AF:
0.652
Gnomad4 NFE exome
AF:
0.641
Gnomad4 OTH exome
AF:
0.661
GnomAD4 genome
AF:
0.648
AC:
98365
AN:
151910
Hom.:
31980
Cov.:
32
AF XY:
0.648
AC XY:
48099
AN XY:
74242
show subpopulations
Gnomad4 AFR
AF:
0.632
Gnomad4 AMR
AF:
0.605
Gnomad4 ASJ
AF:
0.705
Gnomad4 EAS
AF:
0.788
Gnomad4 SAS
AF:
0.763
Gnomad4 FIN
AF:
0.647
Gnomad4 NFE
AF:
0.643
Gnomad4 OTH
AF:
0.649
Alfa
AF:
0.650
Hom.:
60932
Bravo
AF:
0.645
TwinsUK
AF:
0.642
AC:
2380
ALSPAC
AF:
0.640
AC:
2465
ESP6500AA
AF:
0.631
AC:
2778
ESP6500EA
AF:
0.646
AC:
5551
ExAC
AF:
0.665
AC:
80783
Asia WGS
AF:
0.705
AC:
2454
AN:
3476
EpiCase
AF:
0.645
EpiControl
AF:
0.642

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 29, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Achromatopsia 3 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 28, 2019
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Achromatopsia Benign:1
Nov 18, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Severe early-childhood-onset retinal dystrophy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.47
T
Eigen
Benign
-0.20
Eigen_PC
Benign
-0.023
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.0000017
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.99
L
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.092
Sift
Benign
0.27
T
Sift4G
Benign
0.27
T
Polyphen
0.0050
B
Vest4
0.14
MPC
0.032
ClinPred
0.013
T
GERP RS
4.2
Varity_R
0.28
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4961206; hg19: chr8-87666251; COSMIC: COSV60684928; COSMIC: COSV60684928; API